In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea

Parasitology

Volumn 137, Issue 11, 2010, Pages 1661-1670

  Veiga Santos, P ^a   Pelizzaro Rocha, K J ^b   Santos, A O ^b   Ueda Nakamura, T ^a   Filho, B P Dias ^a   Silva, S O ^a   Sudatti, D B ^c   Bianco, E M ^c   Pereira, R C ^c   Nakamura, C V ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

anti trypanosomal activity; elatol; Laurencia dendroidea; mitochondrion; Trypanosoma cruzi

Indexed keywords

ANTITRYPANOSOMAL AGENT; ELATOL; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTI TRYPANOSOMAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MEMBRANE; CELL VACUOLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; ELECTRON MICROSCOPY; EPIMASTIGOTE; ERYTHROCYTE; IC 50; IN VITRO STUDY; INFECTION; LAURENCIA; LAURENCIA DENDROIDEA; MEDICINAL PLANT; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RED ALGA; SCANNING ELECTRON MICROSCOPY; SEAWEED; THIN LAYER CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; TRYPOMASTIGOTE;

ANIMALS; CELL LINE; ERYTHROCYTES; HUMANS; INHIBITORY CONCENTRATION 50; LAURENCIA; MICROSCOPY, ELECTRON; PARASITIC SENSITIVITY TESTS; SPIRO COMPOUNDS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

DENDROIDEA; LAURENCIA; TRYPANOSOMA CRUZI;

EID: 77957324291     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S003118201000034X     Document Type: Article

References (47)

1. Bansemira, A., Justa, N., Michalikb, M., Lindequista, U. and Lalk, M. (2004). Extracts and sesquiterpene derivatives from the red alga Laurencia chondrioides with antibacterial activity against fish and human pathogenic bacteria. Chemistry and Biodiversity 1, 463-467.
2. Brener, Z. (1962). Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina tropical de São Paulo 4, 389-396.
3. Camargo, E. P. (1964). Growth and differentiation in Trypanosoma cruzi. Origen of metacyclic trypanosomes in liquid media. Revista do Instituto de Medicina tropical de São Paulo 6, 93-100.
4. Cassano, V. (2009). Taxonomia e filogenia do complexo Laurencia (Ceramiales, Rhodophyta), com ênfase no estado do Rio de Janeiro, Brasil. Ph. D. thesis. Instituto de Botânica da Secretaria de Estado do Meio Ambiente, São Paulo.
5. Coura, J. R. and Castro, S. L. (2002). A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz 97, 3-24.
6. Da Gama, B. A. P., Pereira, R. C., Soares, A. R., Teixeira, V. L. and Yoneshigue-Valentin, Y. (2003). Is the mussel test a good indicator of antifouling activity? A comparison between laboratory and field assays. Biofouling 19, 161-169.
7. Dantas, A. P., Salomão, K., Barbosa, H. S. and Castro, S. L. (2006). The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells. Memórias do Instituto Oswaldo Cruz 101, 207-211.
8. de Nys, R., Leya, T., Maximilien, R., Afsar, A., Nair, P. S. R. and Steinberg, P. D. (1996). The need of standardised broad scale biossay testing: a case study using the red algae Laurencia rigida. Biofouling 10, 213-224.
9. Freile-Pelegrin, Y., Robledo, D., Chan-Bacab, M. J. and Ortega-Morales, B. O. (2008). Antileishmanial properties of tropical marine algae extracts. Fitoterapia 79, 374-377. doi: 10.1016/j.fitote.2008.02.006.
10. Hay, M. E., Fenical, W. and Gustafson, K. (1987). Chemical-defense against diverse coral-reef herbivores. Ecology 68, 1581-1591.
11. Hay, M. E., Duffy, J. E. and Fenical, W. (1988). Seaweed chemical defenses: among-compound and among-herbivore variance. Proceedings of the 6th International Coral Reef Symposium 3, 43-48.
12. Iliopoulou, D., Roussis, V., Pannecouque, C., De Clercq, E. and Vagias, C. (2002). Halogenated sesquiterpenes from the red alga Laurencia obtusa. Tetrahedron 58, 6749-6755. doi: 10.1016/S0040-4020 (02) 00687-7.
13. Izumi, E., Morello, L. G., Ueda-Nakamura, T., Yamada-Ogatta, S. F.; Dias-Filho, B. P., Cortez, D. A. G., Ferreira, I. C. P., Morgado-Días, J. A. and Nakamura, C. V. (2008). Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Experimental Parasitology 118, 324-330. doi:10.1016/j.exppara.2007.08.015. (Pubitemid 351192975)
14. Kang, J. Y., Khan, M. N. A., Park, N. H., Cho, J. Y., Lee, M. C., Fujii, H. and Hong, Y. K. (2008). Antipyretic, analgesic, and anti-inflammatory activities of the seaweed Sargassum fulvellum and Sargassum thunbergii in mice. Journal of Ethnopharmacology 116, 187-190. doi: 10.1016/j.jep. 2007.10.032.
15. Kladi, M., Vagias, C., Stavri, M., Rahman, M. M., Gibbons, S. and Roussis, V. (2008). C15 acetogenins with antistaphylococcal activity from the red alga Laurencia glandulifera. Phytochemistry Letters 1, 31-36. doi: 10.1016/j.phytol.2007.12.004. (Pubitemid 351453831)
16. König, G. M. and Wright, A. D. (1997). Sesquiterpene content of the antibacterial dichlormethane extract of the red alga Laurencia obtusa. Planta Medica 63, 186-187. doi: 10.1055/S-2006-957643.
17. Luize, P. S., Tiuman, T. S., Morello, L. G., Maza, P. K., Ueda-Nakamura, T., Dias-Filho, B. P., Cortez, D. A. G., Mello, J. C. P. and Nakamura, C. V. (2005). Effects of medicinal plant extracts on growth of Leishmania (L.) amazonensis and Trypanosoma cruzi. Brazilian Journal of Pharmaceutical Sciences 41, 85-94.
18. Luize, P. S., Ueda-Nakamura, T., Dias-Filho, B. P., Cortez, D. A. G. and Nakamura, C. V. (2006). Activity of neolignans isolated from Piper regnellii (MIQ.) C. DC. var. pallescens (C. DC.) YUNCK against Trypanosoma cruzi. Biological Pharmaceutical Bulletin 29, 2126-2130.
19. Matsuhiro, B., Conte, A. F., Damonte, E. B., Kolender, A. A., Matulewicz, M. C., Mejías, E. G., Pujol, C. A. and Zúñiga, E. A. (2005). Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta). Carbohydrate Research 340, 2392-2402. doi:10.1016/j.carres.2005.08.004. (Pubitemid 41375758)
20. Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S. and Hamann, M. T. (2009). Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochimica et Biophysica Acta 1790, 283-308. doi: 10.1016/j.bbagen. 2009.03.011.
21. Mendiola-Martínez, J., Hernández, H., Acuña, D., Esquivel, M., Scull, Lizama, R. and Abreu-Payrol, J. (2005). Inhibiting activity of the in vitro growth of Plasmodium falciparum of extracts from algae of genus Laurencia. Revista Cubana de Medicina Tropical 57, 192-195.
22. Menezes, D., Valentim, C., Oliveira, M. F. and Vannier-Santos, M. A. (2006). Putrescine analogue cytotoxicity against Trypanosoma cruzi. Parasitology Research 98, 99-105. doi: 10.1007/S00436-005-0010-1. (Pubitemid 41799611)
23. Menna-Barreto, R. F. S., Corrêa, J. R., Pinto, A. V., Soares, M. J. and Castro, S. L. (2007). Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone. Parasitology Research 101, 895-905. doi: 10.1007/s00436-007- 0556-1. (Pubitemid 47228793)
24. Menna-Barreto, R. F. S., Gonçalves, R. S. L., Costa, E. M., Silva, R. S. F., Pinto, A. V., Oliveira, M. F. and de Castro, S. L. (2009). The activity on Trypanosoma cruzi of novel synthetic naphthoquinones is mediated by mitochondrial dysfunction. Free Radical Biology and Medicine 47, 644-653. doi: 10.1016/j.freeradbiomed.2009.06.004.
25. Moo-Puc, R., Robledo, D. and Freile-Pelegrin, Y. (2008). Evaluation of selected tropical seaweeds for in vitro anti-trichomonal activity. Journal of Ethnopharmacology 120, 92-97. doi: 10.1016/j.jep. 2008.07.035.
26. Moreira, D. R. M., Leite, A. C. L., Santos, R. R. and Soares, M. B. P. (2009). Approaches for the development of new anti-Trypanosoma cruzi agents. Current Drug Targets 10, 212-231.
27. Nara, T., Kamei, Y., Akiko, T., Annoura, T., Hirota, K., Iizumi, K., Dohmoto, Y., Ono, T. and Aoki, T. (2005). Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells. Parasitology International 54, 59-64. doi: 10.1016/j.parint.2004.11.001. (Pubitemid 40248727)
28. Orhan, I., Sener, B., Atici, T., Brun, R., Perozzo, R. and Tasdemir, D., (2006). Turkish freshwater and marine macrophyte extracts show in vitro anti-protozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. Phytomedicine 13, 388-393. doi: 10.1016/j.phymed.2005. 10.010. (Pubitemid 44250789)
29. Prata, A. (2001). Clinical and epidemiological aspects of Chagas disease. The Lancet Infectious Diseases 1, 91-100. doi: 10.1016/S1473-3099 (01) 00065-2.
30. Salas, C. A., Tapia, R. A., Ciudad, K., Armstrong, V., Orellana, M., Kemmerling, U., Ferreira, J., Maya, J. D. and Morello, A. (2008). Trypanosoma cruzi: Activities of lapachol and a-and b-lapachone derivatives against epimastigote and trypomastigote forms. Bioorganic & Medicinal Chemistry 16, 668-674. doi:10.1016/j.bmc.2007.10.038. (Pubitemid 351175641)
31. Salgado, L. T., Viana, N. B., Andrade, L. R., Leal, R. N., Gama, B. A. P., Attias, M., Pereira, R. C. and Amado Filho, G. M. (2008). Intra-cellular storage, transport and exocytosis of halogenated compounds in marine red alga Laurencia obtusa. Journal of Structural Biology 162, 345-355. doi: 10.1016/j.jsb.2008.01.015.
32. Schaeffer, D. J. and Krylov, V. S. (2000). Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicology and Environmental Safety 45, 208-227. doi: 10.1006/eesa.1999.1862. (Pubitemid 30154583)
33. Schmunis, G. A. (2007). Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Memórias do Instituto Oswaldo Cruz 102, 75-85.
34. Sims, J. J., Lin, G. H. Y. and Wing, R. M. (1974). Marine natural products: elatol, a halogenated sesquiterpene alcohol from the red alga Laurencia elata. Tetrahedron Letters 39, 3487-3490.
35. Steinberg, P. D., De Ny, R. and Kjelleberg, S. (1998). Chemical inhibition of epibiota by Australian seaweeds. Biofouling 12, 227-244.
36. Sudatti, D. B., Rodrigues, S. V., Coutinho, R., Gama, B. A. P., Salgado, L. T., Amado Filho, G. M. and Pereira, R. C. (2008). Transport and defensive role of elatol at the surface of the red seaweed Laurencia obtusa (CERAMIALES, RHODOPHYTA). Journal of Phycology 44, 584-591. doi: 10.1111/j.1529-8817.2008. 00507. X.
37. Tonin, T. D., Barbosa, V. A., Bocca, C. C., Ramos, E. R. F., Nakamura, C. V., Costa, W. F., Basso, E. A., Ueda-Nakamura, T. and Sarragiotto, M. H. (2009). Comparative study of the trypanocidal activity of the methyl 1-nitrophenyl-1, 2, 3, 4-9H-tetrahydro-β-carboline-3-carboxylate derivatives and benznidazole using theoretical calculations and cyclic voltammetry. European Journal of Medicinal Chemistry 44, 1745-1750. doi:10.1016/j.ejmech.2008.03.044.
38. Topcu, G., Anydoqmus, Z., Imre, S., Goren, A. C., Pezzuto, J. M., Clement, J. A. and Kingston, D. G. (2003). Brominated sesquiterpenes from the red alga Laurencia obtusa. Journal of Natural Products 66, 1505-1508.
39. Urbina, J. A. and Docampo, R. (2003). Specific chemotherapy of Chagas disease: controversies and advances. TRENDS in Parasitology 19, 495-501. doi:10.1016/j.pt.2003.09.001. (Pubitemid 37329658)
40. Urbina, J. A. (2009). Ergosterol biosynthesis and drug development for Chagas disease. Memórias do Instituto Oswaldo Cruz 104, 311-318.
41. Vairappan, C. S., Suzuki, M., Abe, T. and Masuda, M. (2001). Antibacterial halogenated metabolites from the Malaysian Laurencia species. Phytochemistry 58, 291-297. doi: S0031-9422 (01) 00260-6. (Pubitemid 32847309)
42. Vairappan, C. S. (2003). Potent antibacterial activity of halogenated metabolites from Malaysian red algae, Laurencia majuscule (Rhodomelaceae, Ceramiales). Biomolecular Engineering 20, 255-259. doi:10.1016/S1389-0344 (03) 00067-4.
43. Valdez, R. H., Tonin, L. T. D., Ueda-Nakamura, T., Dias-Filho, B. P. D., Morgado-Díaz, J. A., Sarragiotto, M. H. and Nakamura, C. V. (2009). Biological activity of 1, 2, 3, 4-tetrahydro-β-carboline-3-carboxamides against Trypanosoma cruzi. Acta Tropica 110, 7-14. doi: 10.1016/j.actatropica. 2008.11.008.
44. Van-Hellemond, J. J., Opperdoes, F. R. and Tielens, A. G. (2005). The extraordinary mitochondrion and unusual citric acid cycle in Trypanosoma brucei. Biochemical Society Transactions 33, 967-971.
45. Wang, B., Zhang, W., Duan, X. and Li, X. (2009). In vitro antioxidative activities of extract and semi-purified fractions of the marine red alga, Rhodomela confervoides (Rhodomelaceae). Food Chemistry 113, 1101-1105. doi: 10.1016/j.foodchem.2008.08.078.
46. WHO/TDR - World Health Organization (2006). Report of the Scientific Working Group on Chagas disease, Buenos Aires, Argentina, p. 7.
47. Wright, A. D., König, G. M., Angerhofer, C. K., Greenidge, P., Linden, A. and Desqueyroux-Faundez, R. (1996). Anti-malarial activity: the search for marine-derived natural products with selective anti-malarial activity. Journal of Natural Products 59, 710-716.